The Zacks Industry Rank assigns a rating to each of the 265 industries based on their average Zacks Rank. An industry with a larger percentage of Zacks Rank #1s (Strong Buy) and #2s (Buy) will have a better Zacks Industry Rank than one with a larger percentage of Zacks Rank #4s (Sell) and #5s (Strong Sell).
Finding the best industries is often the key to success in investing. Our research shows that the industries ranked in the top half outperform those in the bottom half by a factor of two to one, so putting your money to work in the best industries gives you a big advantage.
One space that should be on your radar right now is the medical services industry. The industry has moved up 19 Zacks Industry Ranks in the last week. Stocks within the medical services sector sit in the top 19% of all industries of all 265 industries ranked on the Zacks Industry Rank.
Right now, the medical services space is ranked as the 51st best industry out of the 265 industries covered by Zacks. In the last week, the industry has seen its average Zacks Rank improve, and it has gone from an average Zacks Rank of 2.81 to a rank of 2.74.
Best of the Group
There are several promising choices in this industry right now, such as AMN Healthcare Services AHS , Biotelemetry Inc. BEAT , and HealthEquity Inc. HQY , all of which have either a #1 (Strong Buy) or #2 (Buy) on the Zacks Rank.
The Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
BIOTELEMETRY (BEAT): Free Stock Analysis Report
AMN HLTHCR SVCS (AHS): Free Stock Analysis Report
HEALTHEQUITY (HQY): Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
